Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter co... by Yoshihiko Tasaki, Shuzo Hamamoto, Shimpei Yamashita, Junya Furukawa, Kazutoshi Fujita, Ryotaro Tomida, Makito Miyake, Noriyuki Ito, Hideto Iwamoto, Yoshihisa Mimura, Yosuke Sugiyama, Rei Unno, Atsushi Okada, Takahiro Yasui, Yoko Furukawa-Hibi

Subjects: Get full text

Muscle weakness, myositis and scleroderma induced by durvalumab by Josu Aguado Suquia, Pilar Carballosa de Miguel, Alba Naya Prieto, Maria Jesus Lobo Rebollo, Teresa Blázquez Sánchez, Sarah Béatrice Heili Frades

Subjects: Get full text

Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy by Jennifer Strong, BS, Vincent I. Poon, MD, Patrick Hallaert, BS, Deneise Francis, RN, Danielle M. Pastor, DO, PhD, Leslie Castelo-Soccio, MD, PhD, Julius Strauss, MD, Isaac Brownell, MD, PhD

Subjects: Get full text

Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter Study by Takashi Hatori, Takeshi Numata, Toshihiro Shiozawa, Manato Taguchi, Hirofumi Sakurai, Tomohiro Tamura, Jun Kanazawa, Hiroaki Tachi, Kyoko Kondo, Kunihiko Miyazaki, Norihiro Kikuchi, Koichi Kurishima, Hiroaki Satoh, Nobuyuki Hizawa

Subjects: Get full text

Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors by Ichiro Yamauchi, Daisuke Yabe

Subjects: “…immune-related adverse event…”
Get full text

Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single‐center case series by Joshua Longinow, Mohammad Zmaili, Warren Skoza, Nicholas Kondoleon, Robert Marquardt, Cassandra Calabrese, Pauline Funchain, Rohit Moudgil

Subjects: Get full text

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report by Camille M. Powers, Hannah Verma, Jeremy Orloff, Austin J. Piontkowski, Amy Tiersten, Angela Lamb, Nicholas Gulati

Subjects: “…Cutaneous immune-related adverse event…”
Get full text

Postoperative pyoderma gangrenosum in a patient undergoing long-term nivolumab therapy by Miki Sato, Miki Sato, Kazuhiro Kawai, Akira Yamada

Subjects: Get full text

CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies by Lena Gockeln, Florian Wirsdörfer, Verena Jendrossek

Subjects: Get full text

Revival of recombinant IL-2 therapy – approaches from the past until today by Luise A. Roser, Charline Sommer, Samira Ortega Iannazzo, Christina Sakellariou, Zoe Waibler, Patricia Gogesch

Subjects: “…Immune-related adverse event…”
Get full text

Pembrolizumab Induced Recall Dermatitis Occurring 5 Years After Radiotherapy by Caroline J. Cushman, Fuad Abaleka, Andrew F. Ibrahim, Kiran Yalamanchili, Seshadri Thirumala, Donald Quick

Subjects: Get full text

Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report by Tomoyuki Otsuka, Yoshiki Kojitani, Fumio Imamura, Junko Fukutake, Minako Nishio, Takashi Fujii, Toshihiro Kudo

Subjects: Get full text

Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations by Benjamin C. Park, Sathya Narayanan, Alexander Gavralidis, Fei Ye, Run Fan, Ryan J. Sullivan, Genevieve Boland, Kerry L Reynolds, Justin M. Balko, Matteo S. Carlino, Georgina V. Long, Leyre Zubiri, Alexander M. Menzies, Douglas B. Johnson

Subjects: Get full text

Editorial: Tumor microenvironment and beyond: imaging systemic immunity with PET by Jelena Levi, Israt S. Alam, Tomomi W. Nobashi

Subjects: Get full text

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs by Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, Ihor Arkhypov, Samantha Lasser, Jochen Utikal, Viktor Umansky

Subjects: “…Immune-related adverse events…”
Get full text

Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related pneumonitis triggered by immunotherapy followed by radiation: a case report by Yan Zhu, Jianhe Yu, Qun Ren, Xiang Wu, Hongxia Xu, Tian Tian, Jiang Liu

Subjects: Get full text

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA... by Ruichen Gao, Wenjun Liang, Jintao Chen, Mingxia Yang, Xiaowei Yu, Xiaohua Wang

Subjects: Get full text

Spontaneous haematoma: A unique immune-related adverse event alongside other cutaneous reactions in a patient treated with pembrolizumab for metastatic melanoma by Dalila Malek, Paul Gatt

Subjects: “…Immune related adverse events…”
Get full text

Enteritis of the ileal conduit as an adverse event related to immune checkpoint inhibitor use by Ko Kobayashi, Kohei Hashimoto, Toshiaki Tanaka, Naoya Masumori

Subjects: Get full text

Association of vitiligo with immune-checkpoint inhibitor therapy: A systematic review by Lauren Fleshner, MSc, Katie Roster, MD, Lillian Xie, BS, Shari R. Lipner, MD, PhD

Subjects: “…immune-related adverse events…”
Get full text